ライフサイエンスコーパス: dermatological

1 ion of all major ATC drug categories, except dermatologicals and genito-urinary medications, was sign

2 can aid the design of optimized transdermal, dermatological, and cosmetic formulations in the future.

3 re present in a large number of transdermal, dermatological, and cosmetic products to aid dermal abso

4 The current study focuses on the dermatological aspects of the nkt mutation.

5 We undertook a detailed dermatological assessment, syphilis serology, and PCR on

6 he New York Dermatological Society, American Dermatological Association, American Board of Dermatolog

7 New models of health care delivery for dermatological care have the potential to increase acces

8 The epidemiological and dermatological characteristics of IDH are described, and

9 A dermatological complication of immunosuppression is vira

10 However, applications of siRNA for dermatological conditions are limited by their poor perm

11 aesthetic reasons and for the management of dermatological conditions such as psoriasis and vitiligo

12 e vascular analysis is given for each of the dermatological conditions to show the potential diagnost

13 t of inflammation, Alzheimer's disease (AD), dermatological conditions, hepatic steatosis, and oncolo

14 for the prevention and treatment of numerous dermatological conditions, patients frequently request p

15 d mice treated with topical agents and human dermatological conditions, such as contact dermatitis, a

16 o refer patients for surgery of these common dermatological conditions.

17 easurements in clinical trials, even for non-dermatological conditions.

18 Subsequently, collected dermatological data were subjected to post hoc analysis.

19 Dermatological, developmental, neurological, respiratory

20 Dermatological diagnoses increased from 851 in 2008 to 1

21 anxiety, and suicidal ideation with various dermatological diagnoses.

22 ilar in age and sex who presented with other dermatological diagnoses.

23 that a new measure of disability related to dermatological disease is required.

24 Psoriasis is a common chronic dermatological disease whose prevalence varies among dif

25 For patients with dermatological disease, the Coalition of Skin Diseases (

26 ial insights into this very common childhood dermatological disease.

27 euticals have been generated against several dermatological diseases (PDT) and (antibiotic-resistant)

28 nfection and one of the most frequently seen dermatological diseases in the intensive care unit (ICU)

29 ic modalities for the treatment of pediatric dermatological diseases in the past year.

30 iRNAs are potential therapeutics for various dermatological diseases including psoriasis, atopic derm

31 In the case of dermatological diseases such as alopecia areata, vitilig

32 otential therapeutic applications in various dermatological diseases such as psoriasis, atopic dermat

33 sensitizers for the treatment of cancer and dermatological diseases through photodynamic therapy (PD

34 asis on their applications for investigating dermatological diseases.

35 cally acting PDE4 inhibitor for treatment of dermatological diseases.

36 the skin that can foster the development of dermatological diseases.

37 ally useful for treating certain cancers and dermatological diseases.

38 ion of sensory small fibres due to a primary dermatological disorder can cause neuropathic pain is st

39 mmalian skin as well as their implication in dermatological disorders and the therapy of skin disease

40 Patient registries for dermatological disorders are important sources of data f

41 s are responsible for at least 5 overlapping dermatological disorders associated with syndromic heari

42 za vaccine, and did not have any significant dermatological disorders.

43 e infestations that induce psychological and dermatological distress.

44 ethasone-17-valerate (BMV), a representative dermatological drug, was determined from FFS comprising

45 recently, a novel diaper designed to deliver dermatological formulations to the skin also appears to

46 Genetic, dermatological, haematological, granulomatous, immunosup

47 The Standards for Dermatological Imaging developed by the ISIC members cou

48 Standardizing dermatological imaging is important to improve monitorin

49 he clinical application of the Standards for Dermatological Imaging set forward by the ISIC.

50 lusively associating patient complaints with dermatological implications.

51 with CO2 laser is used for a wide variety of dermatological indications.

52 CCR6 is expressed in a number of dermatological inflammatory diseases.

53 nase inhibitors at levels not detectable via dermatological inspection and histological evaluation.

54 tinal, and of course, in the first instance, dermatological involvement.

55 he ensuing systemic zinc deficiency leads to dermatological lesions and immune and reproductive dysfu

56 No dermatological lesions or weight loss were observed in a

57 toma braziliense is most often implicated in dermatological lesions, and Ancylostoma caninum has been

58 p; most earlier studies were reported in the dermatological literature and may not be familiar to ane

59 gs underscore the need for assessing whether dermatological manifestations are also predictive of car

60 Pulmonary, central nervous system and dermatological manifestations are most common.

61 mutant FGFR2b signaling may account for the dermatological manifestations of AS.

62 was collected, focusing on the most classic dermatological manifestations of IE (Osler nodes, Janewa

63 mong exposed populations do not show classic dermatological manifestations, larger and more comprehen

64 ent of reproductive and sexual function; and dermatological manifestations, mainly represented by acn

65 le in the current issue reports that classic dermatological manifestations, typically associated with

66 Adverse events (typically dermatological) necessitated dose reduction for 61% of p

67 There remains an unmet dermatological need for innovative topical agents that a

68 Chronic itch accompanying many dermatological, neurological, and systemic diseases is u

69 than one patient were gastrointestinal (13), dermatological (nine), metabolic (seven), fatigue (six),

70 eened for anti-MDA5 antibodies at a specific dermatological or pulmonary postallograft consultation b

71 eened for anti-MDA5 antibodies at a specific dermatological or pulmonary postallograft consultation b

72 e of, e.g., environmental factors, aging, or dermatological pathologies.

73 This article reviews relevant dermatological pathophysiology, current treatment modali

74 pivotal role in improving the well-being of dermatological patients.

75 The dermatological perspective brings an alternative view of

76 eurological, psychiatric, immunological, and dermatological phenotypes.

77 As technology becomes more commonplace in dermatological practice, it is essential to continuously

78 up), hot flushes (44 [56%] vs 35 [25%]), and dermatological problems (10 [13%] vs 58 [42%]).

79 designs and materials have aimed at reducing dermatological problems in the diaper area.

80 tries and Yemen, causes blindness and severe dermatological problems.

81 oach may readily be extended to a variety of dermatological processes.

82 testinal and hepatic first-pass effects, and dermatological reactions.

83 n February 2013 and March 2015 at a tertiary dermatological referral center for anal cancer screening

84 We surveyed 802 dermatological research articles from 2012 through 2013.

85 ents unique opportunities and challenges for dermatological research.

86 been one of the biggest challenges of recent dermatological research.

87 his cancer, who would benefit from intensive dermatological screening and immunosuppression reduction

88 represent an innovative model of delivering dermatological services to patients with chronic skin di

89 atologic organizations, such as the New York Dermatological Society, American Dermatological Associat

90 Among 497 definite IE cases, 487 had known dermatological status.

91 The primary outcome measure was the dermatological sum score (DSS) assessing erythema, scali

92 and with high levels of sun exposure, close dermatological surveillance for potential skin malignanc

93 the first reported case of the resolution of dermatological symptoms associated with a PAPA-like synd

94 It can occur in association with dermatological, systemic and neurological diseases, or b

95 s important to evaluate elderly patients for dermatological, systemic, and neurological etiologies of

96 ecrease tumor growth resulted in significant dermatological toxicity.

97 tion of doses of LY294002 that do not induce dermatological toxicity.

98 t method for minimizing bias when evaluating dermatological treatments.